Zentalis Pharmaceuticals
ZNTL
ZNTL
136 hedge funds and large institutions have $261M invested in Zentalis Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-9
Holders Change %
-6.21%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
45
Reduced
40
Closed
35
Calls
$352K
Puts
$431K
Net Calls
-$79K
Net Calls Change
-$293K
Top Buyers
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$3.56M |
| 2 |
AC
2
Almitas Capital
Santa Monica,
California
|
$3.54M |
| 3 |
3
Verition Fund Management
Greenwich,
Connecticut
|
$5.54M |
| 4 |
4
D.E. Shaw & Co
New York
|
$4.15M |
| 5 |
5
Millennium Management
New York
|
$3.26M |
